Javascript must be enabled to continue!
Editorial: Honouring John Hardy – A true pioneer in research
View through CrossRef
AbstractThis Editorial highlights the knighthood recognition of Sir John Hardy, Professor and Chair at the University College London, for his exceptional services to human health and dementia research. We also celebrate his successful trajectory in neurochemistry and neurogenetics, and acknowledge his long‐standing contributions to the Journal of Neurochemistry as an author and editor. John Hardy's research identified key mutations linked to prevalent neurodegenerative diseases in humans and contributed to our understanding of the molecular pathogenesis of Alzheimer disease. As John's career has inspired many generations of researchers in neurochemistry, we present a brief Q&A interview with him on the occasion of his most recent recognition.
image
Title: Editorial: Honouring John Hardy – A true pioneer in research
Description:
AbstractThis Editorial highlights the knighthood recognition of Sir John Hardy, Professor and Chair at the University College London, for his exceptional services to human health and dementia research.
We also celebrate his successful trajectory in neurochemistry and neurogenetics, and acknowledge his long‐standing contributions to the Journal of Neurochemistry as an author and editor.
John Hardy's research identified key mutations linked to prevalent neurodegenerative diseases in humans and contributed to our understanding of the molecular pathogenesis of Alzheimer disease.
As John's career has inspired many generations of researchers in neurochemistry, we present a brief Q&A interview with him on the occasion of his most recent recognition.
image.
Related Results
KONTESTASI TASAWUF SUNNÎ DAN TASAWUF FALSAFÎ DI NUSANTARA
KONTESTASI TASAWUF SUNNÎ DAN TASAWUF FALSAFÎ DI NUSANTARA
<p>This article scrutinizes the history of Islamic development in Nusantara between 15th to 18th centuries, which has been colored from theological mysticism thought. Uniquel...
Korelasi Kadar Karboksihemoglobin terhadap Tekanan Darah Penduduk di Sekitar Terminal Bus Tirtonadi Surakarta
Korelasi Kadar Karboksihemoglobin terhadap Tekanan Darah Penduduk di Sekitar Terminal Bus Tirtonadi Surakarta
<table width="645" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td valign="top" width="408"><p> </p><p>Carbon monoxide is a gas ...
CONJUNTURA
CONJUNTURA
<!--[if gte mso 9]><xml> <o:DocumentProperties> <o:Revision>0</o:Revision> <o:TotalTime>0</o:TotalTime> <o:Pages>1</o:Pages> &...
A Touch of Space Weather - Outreach project for visually impaired students
A Touch of Space Weather - Outreach project for visually impaired students
<p><em><span data-preserver-spaces="true">'A Touch of Space Weather' is a project that brings space weather science into...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
Integrasi Pendidikan Cinta Tanah Air dalam Kurikulum Tersembunyi Berbasis Karakter Kebangsaan
Integrasi Pendidikan Cinta Tanah Air dalam Kurikulum Tersembunyi Berbasis Karakter Kebangsaan
<!--[if gte mso 9]><xml>
<w:WordDocument>
<w:View>Normal</w:View>
<w:Zoom>0</w:Zoom>
<w:TrackMoves/>&...

